Medicare Enrolled
Dr. Virendra Ranadive, MD
Neurology · Fayetteville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ranadive from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ranadive?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ranadive
Dr. Virendra Ranadive is a neurology specialist in Fayetteville, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ranadive performed 10,215 Medicare services across 1,988 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ranadive received a total of $58,218 from 72 pharmaceutical and/or device companies across 1005 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ranadive is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 11% volume in GA
$58,218 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,215
Medicare services
Top 11% in GA for neurology
1,988
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~511 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
7,820 | $5 | $14 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
951 | $60 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
716 | $90 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
346 | $115 | $350 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
124 | $300 | $900 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
73 | $78 | $300 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
50 | $132 | $300 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
40 | $49 | $200 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $42 | $92 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
25 | $139 | $550 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
17 | $102 | $400 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
15 | $160 | $600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$58,218
Total received (2018-2024)
Avg $8,317/year across 7 years
Top 8% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
1,005
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$37,675 (64.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,835 (28.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,708 (6.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,017
2023
$4,327
2022
$4,889
2021
$7,444
2020
$3,870
2019
$13,926
2018
$20,745
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
MDD US Operations, LLC
$449
UCB, Inc.
$290
Teva Pharmaceuticals USA, Inc.
$213
ABBVIE INC.
$200
Novartis Pharmaceuticals Corporation
$165
ACADIA Pharmaceuticals Inc
$151
SK Life Science, Inc.
$144
Lundbeck LLC
$141
Neurocrine Biosciences, Inc.
$136
Neurelis, Inc.
$124
Kyowa Kirin, Inc.
$113
ARGENX US, INC.
$112
Lilly USA, LLC
$102
PFIZER INC.
$80
AstraZeneca Pharmaceuticals LP
$76
Sumitomo Pharma America, Inc.
$66
Alexion Pharmaceuticals, Inc.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$50
SCILEX PHARMACEUTICALS INC.
$45
CSL Behring
$44
Eisai Inc.
$41
Grifols USA, LLC
$39
JAZZ PHARMACEUTICALS INC.
$34
Boston Scientific Corporation
$27
Acorda Therapeutics, Inc
$23
Otsuka America Pharmaceutical, Inc.
$22
SpringWorks Therapeutics, Inc.
$21
Biogen, Inc.
$20
Life Molecular Imaging Ltd
$18
Amneal Pharmaceuticals LLC
$17
Top 3 companies account for 31.6% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$27,163
Supernus Pharmaceuticals, Inc.
$8,700
SK Life Science, Inc.
$2,599
Sunovion Pharmaceuticals Inc.
$2,397
ARGENX US, INC.
$2,003
UCB, Inc.
$1,568
MDD US Operations, LLC
$1,142
ACADIA Pharmaceuticals Inc
$962
ABBVIE INC.
$766
Neurocrine Biosciences, Inc.
$725
Novartis Pharmaceuticals Corporation
$707
Kyowa Kirin, Inc.
$626
Amgen Inc.
$491
Lilly USA, LLC
$491
AbbVie Inc.
$412
Neurelis, Inc.
$396
Amneal Pharmaceuticals LLC
$387
Adamas Pharmaceuticals, Inc.
$378
Acorda Therapeutics, Inc
$357
US WorldMeds, LLC
$349
Alexion Pharmaceuticals, Inc.
$333
Biohaven Pharmaceutical Holding Company Ltd.
$318
PFIZER INC.
$298
CSL Behring
$281
GE HEALTHCARE
$272
Greenwich Biosciences, Inc.
$251
AstraZeneca Pharmaceuticals LP
$247
Biohaven Pharmaceuticals, Inc.
$241
Sumitomo Pharma America, Inc.
$227
Lundbeck LLC
$223
GE Healthcare
$176
Allergan, Inc.
$164
GENZYME CORPORATION
$164
JAZZ PHARMACEUTICALS INC.
$160
Biogen, Inc.
$148
EISAI INC.
$132
UPSHER-SMITH LABORATORIES LLC
$118
Eisai Inc.
$113
Avion Pharmaceuticals
$108
AbbVie, Inc.
$98
Upsher-Smith Laboratories LLC
$97
Grifols USA, LLC
$96
EMD Serono, Inc.
$93
Impax Laboratories, Inc.
$88
IMPEL PHARMACEUTICALS INC.
$78
Avanir Pharmaceuticals, Inc.
$77
IDORSIA PHARMACEUTICALS US INC
$72
Allergan Inc.
$70
Vertical Pharmaceuticals, LLC
$70
Scilex Pharmaceuticals Inc.
$69
Corium, LLC
$61
Alnylam Pharmaceuticals Inc.
$57
W. L. Gore & Associates, Inc.
$54
Takeda Pharmaceuticals U.S.A., Inc.
$50
SCILEX PHARMACEUTICALS INC.
$45
Genentech USA, Inc.
$43
Merck Sharp & Dohme LLC
$38
Otsuka America Pharmaceutical, Inc.
$37
Catalyst Pharmaceuticals, Inc.
$36
Celgene Corporation
$35
OWP Pharmaceuticals, Inc.
$32
Aprecia Pharmaceuticals, LLC
$29
GE HealthCare
$27
Boston Scientific Corporation
$27
ARBOR PHARMACEUTICALS, INC.
$27
SpringWorks Therapeutics, Inc.
$21
Life Molecular Imaging Ltd
$18
Mallinckrodt Enterprises LLC
$17
LivaNova USA, Inc.
$17
Egalet US Inc
$16
Promius Pharma LLC
$15
Assertio Therapeutics, Inc.
$14
Top 3 companies account for 66.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BELSOMRA · BOTOX · BRILINTA · Briviact · CARDIOFORM Septal Occluder · COMIRNATY · COPAXONE · CREXONT · DUOPA · Dhivy · Duopa · EMGALITY · EPIDIOLEX · Epidiolex · FORTEO · FYCOMPA · Fycompa · GOCOVRI · GORE CARDIOFORM Septal Occluder · Gamunex-C · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LEQEMBI · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · REXULTI · REYVOW · RYTARY · Rebif · Rystiggo · SOLIRIS · SPRIX · Soliris · Spritam · Subvenite · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VIIBRYD · VNS - Sentiva · VRAYLAR · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · XCOPRI · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (65%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for neurology in GA.
Geographic Context
Neurologists within 10 mi
114
Per 100K population
94.5
County median income
$108,986
Nearest hospital
PIEDMONT FAYETTE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ranadive is a clinical cardiology specialist, with above-average Medicare volume (top 11% in GA), with speaking/promotional industry engagement in the top 8% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ranadive experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Ranadive performed 7,820 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ranadive receive payments from pharmaceutical companies?
Yes. Dr. Ranadive received a total of $58,218 from 72 companies across 1,005 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ranadive's costs compare to other neurologists in Fayetteville?
Dr. Ranadive's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ranadive) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Fayetteville
Browse neurologists in Fayetteville ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
SK Life Science, Inc. Payments to Doctors
See all physicians who received payments from SK Life Science, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology